舌根鳞状细胞癌单纯放疗或联合化疗的长期疗效
回顾性分析1964至2011年在佛罗里达大学接受根治性放疗(单纯或联合辅助化疗)的467例舌根鳞状细胞癌患者,中位随访5.6年,5年局部控制率85.5%、局部区域控制率80.0%、区域控制率90.0%,5年总生存率59.1%、病因特异性生存率71.5%、无远处转移生存率84.1%,14%发生严重晚期并发症。
要点
- 5年局部、局部区域、区域控制率分别为85.5%、80.0%、90.0%。
- 5年总生存、病因特异性生存、无远处转移生存分别为59.1%、71.5%、84.1%。
- 64例(14%)发生严重晚期并发症,50例(11%)需晚期胃造瘘置管。
核心结论
- 本研究支持对舌根鳞状细胞癌患者继续采用单纯放疗或联合辅助化疗,因该治疗可获得较高的病因特异性生存率和疾病控制率,且晚期并发症发生率相对较低。
研究设计与样本
- 回顾性分析1964年至2011年在佛罗里达大学接受根治性放疗(单纯或联合辅助化疗,伴或不伴计划性颈淋巴结清扫)的467例舌根鳞状细胞癌患者的病历资料。
主要发现
- 中位随访5.6年,原发灶中位总剂量74.4 Gy。
- 87例(19%)接受每日一次分割放疗,380例(81%)接受改变分割方案。
- 128例(27%)接受调强放疗,173例(37%)接受化疗,226例(48%)在放疗后行计划性颈淋巴结清扫。
- 25例患者有p16通路激活数据。
- 5年局部、局部区域、区域控制率分别为85.5%、80.0%、90.0%。
临床怎么用
- 作者认为,本研究支持对舌根鳞状细胞癌患者继续采用单纯放疗或联合辅助化疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To evaluate the long-term disease control, survival, and complications after definitive radiotherapy (RT) alone or combined with adjuvant chemotherapy with or without planned neck dissection for base of tongue squamous cell carcinoma (SCC). STUDY DESIGN: We retrospectively reviewed the medical records of 467 patients treated at the University of Florida with definitive RT alone or combined with adjuvant chemotherapy between 1964 and 2011 for base of tongue SCC. METHODS: Median follow-up was 5.6 years. Median total dose to the primary site was 74.4 Gy. Eighty-seven patients (19%) were treated with once-daily fractionation, and 380 (81%) received altered fractionation schedules. Intensity-modulated RT was used in 128 patients (27%). Chemotherapy was administered to 173 (37%) patients. Planned neck dissection after RT was performed in 226 patients (48%). Data regarding p16 pathway activation were available for 25 patients. RESULTS: At 5 years, the local, local-regional, and regional control rates were 85.5%, 80.0%, and 90.0%, respectively. The 5-year overall, cause-specific, and distant metastasis-free survival rates were 59.1%, 71.5%, and 84.1%, respectively. Sixty-four patients (14%) developed one or more severe late complications. Fifty patients (11%) required late gastrostomy tube placement. CONCLUSIONS: This study supports the continued use of RT alone or combined with adjuvant chemotherapy for patients with base of tongue SCC, as this treatment yields high rates of cause-specific survival and disease control, with a relatively low rate of late complications. LEVEL OF EVIDENCE: 4. Laryngoscope, 127:1589-1594, 2017.
引用
- Christopherson K, Morris CG, Kirwan JM, et al. Radiotherapy alone or combined with chemotherapy for base of tongue squamous cell carcinoma. Laryngoscope. 2017. PMID: 28233903. doi:10.1002/lary.26460
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。